Meridian Bioscience, Inc.

Meridian Bioscience, Inc. — FDA 510(k) Submissions

Meridian Bioscience, Inc. has submitted 38 FDA 510(k) premarket notifications since 2003, of which 37 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Helicobacter Pylori, Devices Detecting Influenza A, B, And C Virus Antigens, Antigens, All Types, Escherichia Coli, Mycoplasma Pneumoniae Dna Assay System, Real Time Nucleic Acid Amplification System . Use the specialty filter in the sidebar to narrow results.